Bioheart (USRM) Stock Price, News & Analysis

Company Overview

Bioheart, Inc. was a biotechnology company focused on regenerative medicine and cell-based therapies for cardiovascular disease. Its primary program, MyoCell, was an investigational autologous cell therapy designed to use a patient’s own skeletal muscle cells in an effort to improve heart function in people with congestive heart failure.

The company also investigated related cell-therapy approaches, including genetically enhanced myoblast programs and other regenerative medicine applications. These products and therapies were developmental in nature and were not described as broadly available approved treatments.

Bioheart was based in Florida and conducted its business primarily in the United States. Publicly available historical information indicates that the company later adopted the name US Stem Cell, Inc.; current operating details and leadership information for Bioheart are limited.

Key Stats

• Today's Range: N/A
• 50-Day Range: N/A
• 52-Week Range: N/A
• Volume: N/A
• Average Volume: 116,490 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Last Earnings: 8/07/2019
• Today: 10/15/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Biotechnology
• Sub-Industry: Biotechnology
• Current Symbol: OTCMKTS:USRM
• Previous Symbol: NASDAQ:BHRT
• CIK: 1388319
• Web: www.us-stemcell.com
• Phone: (954) 835-1500
• Fax: 954-845-9976
• Employees: 11
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: -1.04